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Abstract
Aims/hypothesis Hypoxic damage complicates islet isolation
for transplantation and may contribute to beta cell failure in
type 2 diabetes. Polymorphisms in the SLC30A8 gene,
encoding the secretory granule zinc transporter 8 (ZnT8),
influence type 2 diabetes risk, conceivably by modulating
cytosolic Zn2+ levels. We have therefore explored the role of
ZnT8 and cytosolic Zn2+ in the response to hypoxia of
pancreatic islet cells.
Methods Human, mouse or rat islets were isolated and ex-
posed to varying O2 tensions. Cytosolic free zinc was mea-
sured using the adenovirally expressed recombinant targeted
zinc probe eCALWY4. Gene expression was measured using
quantitative (q)RT-PCR, western (immuno-) blotting or im-
munocytochemistry. Beta cells were identified by insulin
immunoreactivity.
Results Deprivation of O2 (1% vs 5% or 21%) for 24 h
lowered free cytosolic Zn2+ concentrations by ~40%
(p<0.05) and ~30% (p<0.05) in mouse and human islet
cells, respectively. Hypoxia similarly decreased
SLC30A8 mRNA expression in islets, and immunoreac-
tivity in beta cells. Implicating lowered ZnT8 levels in
the hypoxia-induced fall in cytosolic Zn2+, genetic ab-
lation of Slc30a8 from mouse islets lowered cytosolic
Zn2+ by ~40% (p<0.05) and decreased the induction of
metallothionein (Mt1, Mt2) genes. Cell survival in the
face of hypoxia was enhanced in small islets of older
(>12 weeks) Slc30a8 null mice vs controls, but not
younger animals.
Conclusions/interpretation The response of pancreatic beta
cells to hypoxia is characterised by decreased SLC30A8 ex-
pression and lowered cytosolic Zn2+ concentrations. The
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dependence on ZnT8 of hypoxia-induced changes in cell
survival may contribute to the actions of SLC30A8 variants
on diabetes risk in humans.
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WT Wild-type
ZIP Zinc importer
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Introduction
Pancreatic beta cells are highly dependent on oxidative me-
tabolism for ATP synthesis, particularly at elevated glucose
concentrations [1, 2]. Correspondingly, hypoxia has been
shown to influence islet survival and function during trans-
plantation [3, 4]. Moreover, as many as 25% of islets are
exposed in vivo to low oxygenation [5], suggesting that
hypoxia acts as a regulator of islet function under physiolog-
ical conditions. Indeed, glucose-induced oxygen consumption
creates intracellular hypoxia sufficient to activate hypoxia-
inducible factors (HIFs) in rat beta cells [6], an effect that is
increased in diabetic animals [7] and which may contribute to
defective insulin secretion in some forms of type 2 diabetes.
Hypoxic stress induces genes such as metallothionein
(MT1/2) as a defence against large changes in free metal ion
concentration [8], which may affect the activity of anti-
oxidative enzymes [9]. Whether genetic factors influence the
susceptibility of pancreatic beta cells to hypoxia has not
previously been explored. Suggesting this as a possibility,
genome-wide association studies (GWAS) have revealed that
a non-synonymous single nucleotide polymorphism
(rs13266634) in the SLC30A8 gene (encoding the secretory
granule-resident zinc transporter 8 [ZnT8]) is associated with
a ~20% increase in disease risk per allele [10–12]. SLC30A8
expression is largely confined to pancreatic beta and alpha
cells [13], and is required for the accumulation of zinc into the
secretory granule, where it binds to insulin [14, 15]. Conse-
quently, mice inactivated systemically for Slc30a8 display
profound changes in insulin crystal formation and secretory
granule morphology [14, 15], consistent with the lower zinc-
transporting activity of the transporter isoform encoded by the
risk allele [15]. Defective insulin secretion is seen in global
ZnT8−/− mice on some [15], but not all, backgrounds [14, 16,
17], and mice with selectively deleted beta cell Slc30a8 dis-
play marked changes in insulin secretion and glucose toler-
ance [18]. Whether Slc30a8 influences cytosolic, as well as
granular, Zn2+ concentrations has not previously been exam-
ined because of the uncertain subcellular targeting of the
probes used in earlier work [15].
Monitoring cytosolic Zn2+ with the molecularly targeted
recombinant probe eCALWY4 [19], the present study aimed
to explore the impact of hypoxia on Zn2+ homeostasis, and the
expression of SLC30A8/ZnT8 and other zinc transporters and
importers, in human and rodent beta cells.
Methods
Reagents RPMI and CMRL medium, ZnCl2, N,N,N′,N′-
tetrakis(2-pyridylmethyl) ethylenediamine (TPEN),
2-mercaptopyridine N-oxide (pyrithione), poly-L-lysine and
dimethyloxalylglycine (DMOG)were from Sigma (Gillingham,
UK), TRIzol reagent was from Applied Biosystems / Life
Technologies (Paisley, UK).
Mouse and rat strains and maintenance Female CD1 mice
and male Wistar rats were purchased from Harlan (Bicester,
UK/Itingen, Switzerland). Global ZnT8−/− mice [15] on a
mixed SV129/C57BL/6 background and 129S7/
SvEvBrd-Mt1tm1BriMt2tm1Bri/J mice (purchased from
Jackson Laboratory, Bar Harbor, ME, USA) have previously
been described [20]. Mice were killed at 10–12 weeks
(−15weeks for cell death analysis) of age by cervical dislocation
as approved by the UK Home Office Animal Scientific
Procedures Act, 1986 (PPL 70/7349), with ethics approvals.
Islet isolation, culture, infection and dissociation Human
islets were isolated from six beating-heart donors (electronic
supplementary material [ESM] Table 1) with appropriate local
ethical permissions (Charing Cross Research Ethics
Committee reference 07/H0711/114) in Oxford, UK
[21] or in Geneva, Switzerland [22], and maintained in
RPMI medium containing 5.5 mmol/l glucose and 10%
(vol./vol.) FCS. Mouse and rat islets were prepared as
in Ravier and Rutter [23]. Islets were dissociated by
10 min incubation in Hanks’-based enzyme-free cell
dissociation buffer (Gibco, Invitrogen, Paisley, UK),
plated onto 24 mm sterile coverslips treated with 0.1%
poly-L-lysine and allowed to recover overnight in RPMI
medium containing 11 mmol/l glucose.
Hypoxia exposure Pancreatic islets or beta cells were exposed
to hypoxia (1% O2, 5% CO2, 94% N2), normoxia (21% O2,
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5% CO2, 74% N2) or other oxygen concentrations using a
tissue culture incubator with adjustable O2 or a modular
incubator chamber (Billups-Rothenberg, del Mar, CA, USA).
Imaging of free cytosolic Zn2+ concentrations Adenovirus
expressing the recombinant Zn2+ probe eCALWY-4 was gen-
erated as previously described [24]. Virus was added to dis-
sociated islet cells for 4 h. The mediumwas then changed, and
cells were allowed to express the protein for 48 h. For imag-
ing, cells were washed twice in Krebs Hepes-bicarbonate
(KHB) buffer (140 mmol/l NaCl, 3.6 mmol/l KCl,
0.5 mmol/l NaH2PO4, 0.2 mmol/l MgSO4, 1.5 mmol/l CaCl2,
10 mmol/l Hepes [pH 7.4], 2 mmol/l NaHCO3), 11 mmol/l
glucose, pre-equilibrated with 74:21:5 N2:O2:CO2 (normoxia)
or 94:1:5 N2:O2:CO2 (hypoxia). Zn
2+ imaging was carried out
as described previously [19], with perifusion of the infected
beta cell with buffer subsequently supplemented with
50 μmol/l TPEN and then 5 μmol/l pyrithione/100 μmol/l
ZnCl2 (ZnPyr) (Fig. 1a, b). For hypoxia-treated cells, care was
taken to keep oxygen tension low during microscopy by
perifusing cells with oxygen-depleted solutions.
RNA extraction and qRT-PCR Total RNA from ~50 islets was
obtained using TRIzol reagent and reverse-transcribed into
cDNA using a high-capacity cDNA reverse transcription kit
(Applied Biosystems). cDNA (equivalent to 10–20 ng of
RNA) was subject to qRT-PCR using Power SYBR Green
master mix (Applied Biosystems/Life Technologies) in a 7500
fast real-time PCR system (Applied Biosystems/Life
Technologies) and analysed by the comparative Ct method
(primers are shown in ESM Table 2). The expression of target
genes was normalised to the expression of cyclophilin A.
Protein extraction and western (immuno-) blotting analysis
After exposure to normoxia or hypoxia for 24 h, ~200 islets
were washed and lysed in ice-cold radioimmune precipitation
assay buffer. Total protein extracts (30 μg) were resolved by
SDS-PAGE (12% vol./vol. acrylamide) and transferred to
PVDF membranes, followed by immunoblotting with rabbit
anti-rodent ZnT8 antibody (1:200, Mellitech, Grenoble,
France), and mouse monoclonal anti-tubulin (1:5,000, Sigma
clone B-5-1-2) antibodies. Secondary horseradish peroxidase
(HRP)-linked anti-rabbit antibodies (1:10,000, GE
Healthcare, Little Chalfont, UK) were revealed by using
ECL detection reagent (GE Healthcare).
Immunofluorescence Cells were fixed in 3.7% paraformalde-
hyde and permeabilised in 0.1% Triton X-100 before immu-
nostaining with a polyclonal anti-swine insulin antibody
(1:200, DakoCytomation, Ely, UK), anti-glucagon antibody
(G2654, Sigma) and anti-rodent human/rodent ZnT8 antibody
overnight at 4°C. Alexa-coupled secondary antibodies
(Invitrogen) were used to reveal the primary antibody
staining. Confocal imaging was performed as described
elsewhere [15].
Overexpression experiments INS-1 (832/13) rat beta cells
were plated onto 24 mm cover slips and transfected using
Lipofectamine 2000 (Invitrogen) with 0.5 μg/well of plasmid
encoding eCALWY-4 and 1 μg/well of a construct containing
ZnT8 fused in-frame with mCherry (A. Pramatarova, McGill
University, Montreal, Canada). At 48 h after transfection,
cytosolic Zn2+ was imaged as above.
Dead:live cell assay Islets were incubated for 15 min in PBS
containing 3 μmol/l calcein-AM (Life Technologies) and
2.5 μmol/l propidium iodide (PI; Sigma-Aldrich) before
detection of absorbance/emission at 491/525 nm and
561/620 nm, respectively. The islet area occupied by
dead cells (PI) was calculated and expressed as a unitary ratio
vs that occupied by all (live and dead) cells (PI plus calcein)
using ImageJ (http://imagej.nih.gov/ij/) [25].
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Fig. 1 Imaging the effect of hypoxia on [Zn2+]cyt in dissociated islets. (a)
[Zn2+]cyt was measured in dissociated CD1 mouse islets as described in
theMethods section. Scale bar, 10μm. (b) A representative trace showing
changes in citrine/cerulean fluorescence ratio; ZnPyr, 5 μmol/l
pyrithione/100 μmol/l ZnCl2. (c, d) Analysis of [Zn
2+]cyt in dissociated
(c) CD1 mouse and (d) human islets exposed for 24 h to normoxia (white
bars) or hypoxia (black bars). Bars represent mean ± SE. *p<0.05
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Transmission electron microscopy Isolated islets were fixed
and analysed as previously described [26].
Insulin secretion and content Total and secreted insulin were
measured after batch incubation of islets in KHB buffer as
previously described [23].
Statistics Data are given as mean ± SE or relative frequency.
For comparison of continuous variables in two independent
groups, Student’s two-tailed t test was used. Bonferroni cor-
rection was applied for multiple comparisons. Multiple linear
regression was used to assess the effect of different factors on
islet cell death. Avalue of p<0.05 was considered significant.
Statistical analyses were performed using SPSS 18.0 software
(SPSS, Chicago, IL, USA) and Excel 2010 software
(Microsoft, Redmond, WA, USA).
Results
Exposure of pancreatic beta cells to hypoxia decreases
cytosolic free Zn2+ concentrations and Slc30a8/ZnT8
expression Given the previously described role of Zn2+ ions
in the responses of other tissues to hypoxia and ischaemia
[27], we first determined whether lowered oxygen tensions
might affect cytosolic free Zn2+ concentrations ([Zn2+]cyt) in
mouse or human islet cells by using eCALWY4. This
recombinantly expressed probe is confined exclusively to
the cytosolic compartment, and is expected chiefly to report
changes in beta cells which predominate in the islet prepara-
tions used (>70% for rodent islets [28], ~60% in human islets
[29]). A significant lowering in steady-state [Zn2+]cyt of 30–
40% in preparations from either species maintained under
hypoxic conditions (Fig. 1c, d) was detected.
To determine whether changes in the expression of key
regulators of intracellular Zn2+ homeostasis (zinc transporter
[Slc30/ZnT] and zinc importer [Slc39/ZIP] [30] families) are
involved in the hypoxia-induced changes in [Zn2+]cyt, their
expression was measured in control or hypoxia-exposed islets.
Whereas exposure to hypoxia for 24 h exerted no significant
effect on the expression ofmembers of the latter family in both
mice and rats (ESM Fig. 1a, b), marked decreases were
observed in levels of mRNA encoding Slc30a8 in both mouse
and human islets (Fig. 2a, b), as well as rat islets (ESM Fig. 1c).
These changes were accompanied by the expected increase in
the expression of the major islet metallothionein genes, MT1
(also known asMT1A) (Mt1) andMT2 (also known asMT2A)
(Mt2) (Fig. 2b, c). Western blot analysis revealed a significant
decrease in ZnT8 protein abundance during hypoxia exposure
in mouse islets (Fig. 2d). Confirming that the above hypoxia-
induced changes were unlikely to require the more severely
hypoxic conditions that may exist in the islet core [3], or
paracrine intra-islet signalling (e.g. by inflammatory signals)
[31], similar changes in the expression of Slc30a8 and Mt1/2
were apparent in dissociated mouse and human islet cells
after exposure to hypoxia for 24 h (Fig. 3a, b). Corre-
spondingly, a hypoxia-induced decrease in the expression
of ZnT8 at the protein level was readily revealed by
immunocytochemical analysis of individual insulin-
positive mouse beta cells (Fig. 3c). To exclude hyperoxia-
induced Slc30a8 overexpression, we compared the effects of
1%, 5% and 21% oxygen concentrations. Exposure to 1%, but
not 5%, ambient oxygen altered the expression of Slc30a8
compared with 21% ambient oxygen (ESM Fig. 2a). The
0
5
10
15
Re
la
tiv
e 
m
RN
A 
ex
pr
es
si
on
in
 h
um
a
n
 is
le
ts
 (fo
ld
) 
**
0
1
2
3
Mt1 Mt2 Mt3
R
el
at
iv
e 
m
R
N
A 
ex
pr
es
si
on
in
 m
o
u
se
 is
le
ts
 
(fo
ld)
 
0
Slc
30
a1
SL
C3
0A
8
MT
1
MT
2
Slc
30
a2
Slc
30
a3
Slc
30
a4
Slc
30
a5
Slc
30
a6
Slc
30
a7
Slc
30
a8
Slc
30
a9
Slc
30
a1
0
0.2
0.4
0.6
0.8
Re
la
tiv
e 
m
RN
A 
ex
pr
es
si
o
n
in
 m
o
u
se
 is
le
ts
 (fo
ld)
 
a
**
*
b
ZnT8
Tubulin
21% 1%
[O2]d
**
c
*
** **
*
Fig. 2 The effect of hypoxia on the expression of genes implicated in
Zn2+ homeostasis in pancreatic islets. (a, c) CD1 mouse and (b) human
islets were incubated for 24 h at normoxia (white bars) or hypoxia (black
bars). Expression of (a) Slc30a1–10, (b) SLC30A8, MT1, MT2 and (c)
Mt1–Mt3 was determined (normalisation to the expression in normoxia
[b]). Bars represent mean ± SE. *p<0.05 and **p<0.01. (d) Western blot
analysis of CD1 mouse islets after incubation for 24 h at normoxia (21%)
or hypoxia (1%)
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hypoxia-induced changes in Slc30a8mRNA levels, as well as
cytosolic free Zn2+ concentrations in mouse islets/islet cells,
were largely reversible after 24 h of re-oxygenation (ESM
Fig. 2b, c).
To exclude a decrease in cell viability as the chief reason
for the reduced Slc30a8/ZnT8 expression, cell death was
quantified 24 h after exposure to hypoxia. This analysis
revealed a dead:live cell ratio of 12.4±1.9% and 3.9±1.2%
in mouse and human islets, respectively, maintained under
hypoxic conditions, compared with values of 0.7±0.2 and
0.4±0.1% in normoxia (ESM Fig. 3a, b). Correspondingly,
hypoxia did not cause major changes in the morphology or
ultrastructure of surviving islet cells as examined by electron
microscopy (ESM Fig. 3c). As expected [32, 33], characteri-
sation of hypoxic islets revealed reduced glucose-stimulated
insulin secretion: insulin secretion ratio (release at high
[16.7 mmol/l] glucose vs low [3.3 mmol/l] glucose) was
only 4% of the ratio in normoxia (ESM Fig. 3d). Similarly,
KCl-induced insulin secretion was also reduced in hypoxia
(ESM Fig. 3d).
We sought next to determine whether the hypoxia-induced
changes in the expression of Slc30a8/ZnT8might reflect more
global cellular dedifferentiation and/or alterations in the ratio
of different islet cell types. Arguing against these possibilities,
the expression of beta cell-enriched genes including insulin 1
(Ins1) and glucokinase (Gck) (also present in alpha cells) [34]
did not change significantly during hypoxia and re-
oxygenation treatment of mouse islets (Fig. 4a, b). By con-
trast, and as expected, large changes in the expression of the
HIF1α targets GLUT1 (Slc2a1) and solute carrier family 16
(monocarboxylic acid transporters), member 3 (MCT4)
(Slc16a3) were observed (Fig. 4c, d). Similar to the expression
of Slc30a8 (Fig. 4e), expression of pancreatic duodenum
homeobox-1 (Pdx1), a key transcription factor involved in
the regulation of insulin genes and of beta cell differentiation
[35], was markedly decreased by hypoxia (Fig. 4f), and this
change was not as rapidly reversed as those for the mainly
HIF1α-controlled genes (Slc2a1 and Slc16a3) or the
metallothioneins (Mt1, Mt2) (Fig. 4g, h).
To further explore a possible role for HIF1α in controlling
Slc30a8/ZnT8 expression, pancreatic islets were exposed to
the HIF1α-stabilising agent DMOG for 24 h. DMOG
treatment did not significantly affect Slc30a8 expression
(ESM Fig. 4).
Regulation of Slc30a8/ZnT8 by hypoxia does not require
changes in metallothionein gene expression The expression
of Slc30a8/ZnT8 has previously been shown to be regulated
by changes in intracellular free Zn2+ [36], which in turn are
expected to be influenced by alterations in metallothionein
expression.We therefore determinedwhether the regulation of
Slc30a8 expression by hypoxia might be diminished in islets
from mice null forMt1 andMt2 [20]. Hypoxia still resulted in
a marked decrease in Slc30a8 expression in Mt1−/−:Mt2−/−
mice, to a similar extent to that observed in wild-type (WT)
mouse islets (Fig. 5a). Further supporting a metallothionein-
independent effect of hypoxia on Slc30a8 expression in CD1
mouse islets, Slc30a8mRNA levels tended to be decreased as
early as 5 h after the initiation of hypoxia (significant decrease
after 10 h) (Fig. 5b).
While Slc30a8 expression was not affected by the loss of
Mt1 and Mt2, cell survival after exposure to hypoxia was
markedly (~twofold) decreased in Mt1−/−:Mt2−/− islets
compared with controls (Fig. 5c).
Hypoxia-induced metallothionein gene induction and cell
death is modulated by ZnT8 To further explore the signalling
pathway(s) involved in regulating metallothionein expression
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Fig. 3 The effect of hypoxia on the expression of the genes implicated in
Zn2+ homeostasis in dissociated islets. (a) Dissociated CD1 mouse and
(b) human islet cells were incubated for 24 h at normoxia (white bars) or
hypoxia (black bars). qRT-PCR analysis of (a) Slc30a8,Mt1,Mt2 and (b)
SLC30A8 was performed (normalisation to the expression in normoxia).
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and free cytosolic Zn2+ in response to hypoxia, we next asked
whether inactivation of ZnT8 affected these responses. Induc-
tion ofMt1 andMt2 by hypoxia was significantly impaired in
ZnT8−/−mouse islets, consistent with the lower [Zn2+]cyt in the
latter vs WT mouse islet cells (Fig. 6a, b). As expected, Mt1/
Mt2 expression was induced by exogenously added Zn2+ ions
in hypoxia (Fig. 6c). Similar to the observations in hypoxia,
[Zn2+]cyt was lower in islet cells from mice lacking ZnT8 vs
WT islets (Fig. 6d). This difference between WT and ZnT8−/−
islets was no longer observed in hypoxia (Fig. 6e). Conversely,
overexpression of Slc30a8 in the clonal INS1 (832/13) beta
cell line increased [Zn2+]cyt (Fig. 6f). ZnCl2 was able to raise
the expression of the most abundant metallothionein, Mt2, in
hypoxic ZnT8−/− mouse islets to levels similar to those of
hypoxic WT islets (Fig. 6g). In addition to the regulation of
metallothioneins, the expression of other genes important in
the response of the beta cell to hypoxia was assessed
(ESM Fig. 5). In contrast to metallothionein, there was
a tendency for enhanced expression of these genes in ZnT8−/−
islets, reaching statistical significance for Slc16a3 (MCT4)
when compared in WT and ZnT8−/− islets during hypoxia.
Insulin content did not significantly differ between WT and
ZnT8−/− mouse islets in normoxia or hypoxia (ESM Fig. 6).
In contrast to Mt1−/−:Mt2−/− islets, cell survival was not
affected in a large sample of ZnT8−/− mouse islets (Fig. 6h)
exposed to hypoxia. Multiple linear regression revealed a
significant effect of mouse age ( p=0.001) and islet size
( p<0.001), but not genotype, on islet cell survival. However,
when assessed in a defined population of smaller islets
(<120 μmol/l) from older mice (12–15 weeks), we observed
a significant difference in islet cell survival with a survival
advantage of ZnT8−/− mouse islets after 24 h ( p<0.001) or
48 h of hypoxia exposure (p<0.01) (Fig. 6i).
Discussion
We demonstrate here that hypoxia strongly, but reversibly,
regulates the expression of Slc30a8/ZnT8 in islets and beta
cells from human and two rodent species. These findings thus
extend the list of pathophysiological factors, currently includ-
ing cytokines [31, 37] and fatty acids [36], which regulate the
expression of this type 2 diabetes risk gene in islets. Hypoxia
might therefore contribute to the downregulation of Slc30a8
previously observed in human type 2 diabetes islets [38].
The present findings extend to the islet beta cell those of a
recent report [39] showing that hypoxia lowers the expression
of Slc30a8/ZnT8 in the retinal pigment epithelium of the eye.
The latter studies [39] provided evidence for control of ZnT8
levels via HIF1 stabilisation. By contrast, in our hands, the
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Fig. 4 The effect of hypoxia and re-oxygenation on the expression of
genes implicated in beta cell differentiation and function as well as Zn2+
homeostasis. CD1 mouse islets were incubated at normoxia, at hypoxia
for 24 h or hypoxia for 24 h followed by normoxia for 8 h. The qRT-PCR
analysis was performed for (a) Ins1, (b) Gck, (c) Slc2a1, (d) Slc16a3, (e)
Slc30a8, (f) Pdx1, (g) Mt1 and (h) Mt2. Hypox, hypoxia; normox,
normoxia; and reox, re-oxygenated
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HIF1α-stabilising agent DMOG tended only slightly to re-
duce ZnT8 mRNA levels. Instead, our results suggest that the
effects of hypoxia on Slc30a8/ZnT8 expression in pancreatic
islets are more complex andmay conceivably involve changes
in the expression of Pdx1, recently shown to control Slc30a8
expression in clonal beta cells [40].
Recently, Lefebvre and colleagues [36] reported that de-
pletion of intracellular zinc reduced Slc30a8 expression in
human islets, confirming findings in INS-1E cells [41]. These
earlier observations thus raise the possibility that the lowered
cytosolic Zn2+ concentrations reported here during hypoxia
may contribute to the lowering of Slc30a8/ZnT8 expression.
Arguing against this view, addition of extracellular Zn2+
(30 μmol/l ZnCl2) did not rescue the lowering of Slc30a8
mRNA levels after hypoxia (ESM Fig. 7). Moreover, any
direct or indirect (e.g. by alterations in cytosolic Zn2+) effect
of hypoxia-driven metallothionein gene induction also seems
unlikely, as hypoxia-induced changes in Slc30a8 mRNA
levels were not different in Mt1/Mt2−/− mice compared with
control animals (Fig. 5a).
We propose instead a model by which hypoxia initially
depresses Slc30a8 transcription and/or mRNA stability by
mechanisms which remain to be elucidated (as discussed
below). This then leads to a lowering of cytosolic free Zn2+,
and a consequent drop in Mt1/Mt2 expression. The above
sequence of events is supported by the observation of reduced
cytosolic Zn2+ in ZnT8−/− mice compared with controls
(Fig. 6d), and by an increased cytosolic Zn2+ concentration
in clonal pancreatic beta cells when Slc30a8 was
overexpressed (Fig. 6f ).
The observation that cytosolic free Zn2+ is lowered by
ablating Slc30a8, a mediator of Zn2+ uptake into granules,
may at first glance appear surprising. We would stress that the
use here of a molecularly targeted cytosolic Zn2+ probe ex-
cludes uncertainties over the subcellular compartment in
which Zn2+ concentrations are interrogated. So how might
this apparent paradox be explained? First, our data suggest
that ZnT8 may, under normal circumstances, catalyse Zn2+
efflux from granules, in line with bidirectional transport by
ZnT5 [42]. Alternatively, gradual release of Zn2+ from gran-
ules by exocytosis may elevate the extracellular Zn2+ concen-
tration in the medium surrounding WT, but not ZnT8−/−, cells
for which granule Zn2+ content is near zero (see Chimienti
et al and Li et al [13, 43]). The released Zn2+ may then be
recaptured, at least in part, and taken into the cytosol, by
plasma-membrane-located Zn2+-uptake systems (e.g. ZIP1,
voltage-gated Ca2+ channels) [30]. However, we calculate that
release of Zn2+ ions into the medium is likely to increase total
external Zn2+ concentration to only a miniscule extent
(<50 nmol/l) vs a total extracellular concentration of
>6 μmol/l [44], although local concentrations at the cell
surface [14, 43] may be higher.
One of the effects of ZnT8 inhibition and consequently
lowered cytosolic Zn2+ levels was impaired metallothionein
induction in response to hypoxia (Fig. 6a, b). However, this
did not affect islet cell survival under the conditions exam-
ined, despite the fact that islets lacking metallothionein-1 and
-2 exhibited a twofold higher frequency of beta cell death
compared with control islets (Fig. 5c). The latter finding is
consistent with earlier data showing that overexpression of
metallothionein protects islets against hypoxia, leading to
improved islet cell survival [45]. We assume, therefore, that
residual levels of metallothionein (~50%) in ZnT8−/− mouse
islets are sufficient to prevent an increase in cell death.
Unexpectedly, in small islets from older mice, we observed
a significantly lower rate of cell death in ZnT8−/− compared
withWT islets. This finding is in line with our previous report
on glucose homeostasis in these mice, where a compromising
effect of ZnT8 deficiency disappeared with age [15], and
suggests that, with ageing, a deleterious effect of ZnT8 defi-
ciency may revert to one of protection. On the other hand, the
lack of a genotype effect in large islets may be due to the
variance of oxygen concentration in these islets, where the
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Fig. 5 The effect of hypoxia on the expression of Slc30a8 and cell death
in mouse pancreatic islets deficient for metallothioneins 1 and 2. Islets
from WT 129S1/SvImJ and 129S7/SvEvBrd-Mt1tm1BriMt2tm1Bri/J mice
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(a) The qRT-PCR analysis of Slc30a8 was performed. (b) CD1 mouse
islets were incubated for 0 h (white bars), 5 h (grey bars) or 10 h (black
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core is relatively anoxic as a consequence of larger diffusion
distance when exposed to hypoxia in vitro. Nonetheless, the
expression of hypoxia-inducible genes (with the exception of
Mt1/Mt2) tended to be enhanced in ZnT8−/− mice, possibly
reflecting regulation of HIF1α by Zn2+ [46]. Importantly, the
current results may provide an explanation for the recent
finding that rare loss-of-function mutations in the SLC30A8
gene in man are associated with protection against type 2
diabetes [47].
Reduced expression of ZnT8 in hypoxia may thus reflect
an ‘adaptive’ response of beta cells to permit survival under a
hypoxic/oxidative stress in a less differentiated state (as pre-
viously described after partial pancreatectomy-induced
hyperglycaemia [48]). The mechanisms behind this observa-
tion remain to be elucidated, but may suggest that reduced
zinc levels are beneficial in the situation of increased hypoxic
stress. Indeed, it has previously been shown that high concen-
trations of Zn2+ are able to induce islet cell death in a dose-
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expression of Mt1 and Mt2 and [Zn2+]cyt as well as cell death rate in
mouse pancreatic islets. Islets from ZnT8+/+ (WT) and ZnT8−/−mice were
incubated for 24 h at normoxia (white bars) or hypoxia (black bars).
qRT-PCR analysis of (a)Mt1 and (b)Mt2was performed. (c) CD1mouse
islets were incubated for 24 h at normoxia or hypoxia, with or without
30 μmol/l extracellular ZnCl2 (white bars, normoxia without ZnCl2; grey
bars, normoxia with ZnCl2; dark grey bars, hypoxia without ZnCl2; black
bars, hypoxia with ZnCl2); qRT-PCR analysis of Mt1 and Mt2 was
performed. (d, e) [Zn2+]cyt was measured in dissociated islets of
ZnT8+/+ (WT) and ZnT8−/− (knockout) mice after incubation for 24 h at
(d) normoxia or (e) hypoxia. (f) Analysis of free [Zn2+]cyt in INS-1(832/13)
cells expressing plasmid constructs encoding ZnT8 carrying either
the at-risk R325 or the protective W325 polymorphism, compared
with control (Ctrl). (g) Islets from ZnT8+/+ (WT, white bars) and
ZnT8−/− mice (black bars) were incubated for 24 h at hypoxia,
with or without 30 μmol/l extracellular ZnCl2 (Zn). qRT-PCR of
Mt2 was performed. (h, i) The proportion of dead cells in islets
of ZnT8+/+ (white bars) and ZnT8−/− mice (black bars) is depicted
(h) after incubation of islets of all sizes for 24 h at normoxia or
hypoxia in mice aged 10–15 weeks, and (i) for islets <120 μm in
older mice (>12 weeks). Bars represent mean ± SE. *p<0.05,
**p<0.01 and ***p<0.001. Hypox, hypoxia; normox, normoxia;
Zn, extracellular ZnCl2
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dependent manner [49, 50]. A similar rate of cell death after
24 h and 48 h of hypoxia, as observed here, suggests that, once
adapted to hypoxia, islets are better able to survive. Further
studies will be required, however, to determine whether phar-
macological modification of ZnT8 function may be beneficial
in islet transplantation or type 2 diabetes mellitus.
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